We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+9.24%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$109B
AUM Growth
+$6.58B
Cap. Flow
-$2.53B
Cap. Flow %
-2.32%
Top 10 Hldgs %
11.22%
Holding
2,919
New
123
Increased
1,147
Reduced
1,380
Closed
157

Sector Composition

Rank Sector Weight
1 Technology 17.78%
2 Industrials 13.97%
3 Financials 11.99%
4 Consumer Discretionary 10.9%
5 Healthcare 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OTLK icon
2651
Outlook Therapeutics
OTLK
$191M
$24K ﹤0.01%
885
+195
+28% +$6.96K
SEEL
2652
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$23K ﹤0.01%
4
CARM
2653
DELISTED
Carisma Therapeutics
CARM
$22K ﹤0.01%
1,378
-19
-1% -$382
ADVM
2654
DELISTED
Adverum Biotechnologies
ADVM
$21K ﹤0.01%
1,171
-21
-2% -$420
DARE icon
2655
Dare Bioscience
DARE
$21M
$21K ﹤0.01%
892
+46
+5% +$946
SLDB icon
2656
Solid Biosciences
SLDB
$900M
$21K ﹤0.01%
792
-24
-3% -$734
TXMD icon
2657
TherapeuticsMD
TXMD
$24M
$21K ﹤0.01%
1,174
-29
-2% -$869
NBEV
2658
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$21K ﹤0.01%
20,289
+1,002
+5% +$1.32K
OSG
2659
DELISTED
Overseas Shipholding Group Inc.
OSG
$20K ﹤0.01%
10,526
-324
-3% -$627
CFMS
2660
DELISTED
Conformis, Inc. Common Stock
CFMS
$19K ﹤0.01%
996
-97
-9% -$2.48K
XELA
2661
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$19K ﹤0.01%
5
+1
+25% +$5.87K
AMPE
2662
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$17K ﹤0.01%
98
+9
+10% +$3.36K
MBII
2663
DELISTED
Marrone Bio Innovations, Inc.
MBII
$17K ﹤0.01%
22,936
-597
-3% -$483
GORO icon
2664
Goldgroup Mining Inc.
GORO
$191M
$16K ﹤0.01%
10,199
-202,299
-95% -$367K
PTN
2665
Palatin Technologies
PTN
$13.8M
$16K ﹤0.01%
25
-1
-4% -$593
ATNX
2666
DELISTED
Athenex, Inc. Common Stock
ATNX
$15K ﹤0.01%
541
-17
-3% -$718
DS
2667
DELISTED
Drive Shack Inc.
DS
$15K ﹤0.01%
10,717
-333
-3% -$733
SVRA icon
2668
Savara
SVRA
$1.19B
$14K ﹤0.01%
11,430
+671
+6% +$798
MARK
2669
DELISTED
Remark Holdings, Inc.
MARK
$14K ﹤0.01%
1,453
+107
+8% +$1.39K
WATT icon
2670
Energous
WATT
$102M
$13K ﹤0.01%
+17
New +$17.6K
GPUS
2671
Hyperscale Data Inc
GPUS
$55.4M
0
TRVN
2672
DELISTED
Trevena, Inc.
TRVN
$13K ﹤0.01%
36
-1
-3% -$554
DMK
2673
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$13K ﹤0.01%
300
-9
-3% -$561
EMAN
2674
DELISTED
eMagin Corporation
EMAN
$13K ﹤0.01%
10,045
-288
-3% -$576
CASI
2675
DELISTED
CASI Pharmaceuticals
CASI
$12K ﹤0.01%
1,525
+78
+5% +$777

Similar funds

Victory Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Victory Capital Management held 2,919 positions worth $109B, up 6.4% from $102B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Victory Capital Management's Q4 2021 filing shows 123 new, 1,147 increased, 1,380 reduced and 157 closed positions. Its largest new stake was Victory Portfolios II VictoryShares Core Plus Bond ETF: 7,796,100 shares worth $194M. The largest sale was HILL-ROM HOLDINGS, INC., an estimated $373M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.

  • Victory Capital Management's largest Q4 2021 buy was Victory Portfolios II VictoryShares Core Plus Bond ETF: 7,796,100 shares worth $194M.
  • Victory Capital Management added most to Global Payments in Q4 2021, an estimated $382M increase.
  • Victory Capital Management's biggest Q4 2021 reduction was Highwoods Properties, cutting an estimated $199M.
  • Victory Capital Management fully exited HILL-ROM HOLDINGS, INC. in Q4 2021, selling an estimated $373M.
  • Victory Capital Management's ten largest holdings make up 11% of its $109B portfolio in Q4 2021.
  • Victory Capital Management opened 123 new positions and closed 157 in Q4 2021.
  • Victory Capital Management's portfolio value rose 6.4% quarter-over-quarter to $109B.

Based on Victory Capital Management's 13F filing for Q4 2021, filed 7 Feb 2022.